AtheroMed was a privately-held medical device company based in Menlo Park, California, dedicated to developing innovative technology for treating peripheral arterial disease. The company developed the Phoenix Atherectomy System, which received FDA clearance in January 2014. AtheroMed was acquired by Volcano Corporation in May 2014 for $115 million plus milestone payments.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account